Table 2.

Training and test set results.1

Patient GroupHigh sensitivity (1/3)High specificity (2/3)Conditional qualitative
Positive/tested% PositivePositive/tested% PositivePositive/tested% Positive
Training set results
 Stage I10/22457/223210/2245
 Stage II32/388425/386631/3882
 Stage III28/348220/345927/3479
 Stage IV3/31003/31003/3100
 Stages I–III70/947452/945568/9472
 All cancer73/977555/975771/9773
 Controls23/17213 (87)24/1722 (98)12/1727 (93)
Test set results
 Stage I10/19535/19269/1947
 Stage II30/407524/406029/4073
 Stage III21/277818/276720/2774
 Stage IV4/41003/4754/4100
 Stages I–III61/867147/865558/8667
 All cancer65/907250/905662/9069
 Controls22/15514 (86)7/1555 (95)17/15511 (89)